BioSpace News Archive

Business

Applied DNA Announces Selected Preliminary Unaudited Fiscal Fourth Quarter and Year End Results

Revenues increased 13% to $4.8 million as compared to $4.2 million in the prior fiscal year.

December 15, 2017

·

6 min read

Lone Star Bio

ESSA Announces Filing of Prospectus Supplement and an Update to Previously Announced Equity Offering

The Company intends to issue up to 75,000,000 units of the Company at a price of US$0.20 per Unit for aggregate gross proceeds of up to US$15 million.

December 15, 2017

·

6 min read

Business

Spero Therapeutics Announces 3Q17 Operating Results and Pipeline Update

The Company reported a net loss of $(12.1) million, or basic and diluted net loss per common share of $(36.02), for the third quarter of 2017.

December 15, 2017

·

10 min read

Orthocell Granted European Tendon Regeneration Patent

Regenerative medicine company Orthocell is pleased to announce it has been granted a key European Patent.

December 15, 2017

·

3 min read

Policy

Takeda And Tigenix Announce That Cx601 (Darvadstrocel) Has Received a Positive CHMP Opinion to Treat Complex Perianal Fistulas in Crohn’s Disease

This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe.

December 15, 2017

·

12 min read

Beleave Provides Business Update

The issuance of a sales license under the ACMPR is in part dependent upon the completion of a satisfactory pre-sale inspection by Health Canada.

December 15, 2017

·

2 min read

Drug Development

Espero BioPharma Provides Corporate Update and 2018 Objectives

Espero BioPharma today announced a strategic update on its clinical and regulatory strategies for tecarfarin, an oral anticoagulant.

December 15, 2017

·

6 min read

Pharm Country

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) of 10,000 Shares of Its Common Stock

The awards were made pursuant to the NASDAQ inducement grant exception as a component of the new hires’ employment compensation.

December 15, 2017

·

1 min read

Biotech Bay

Pulse Biosciences Grants Equity Inducement Awards to New Employees

The options have an exercise price of $24.78 per share, which is equal to the closing price of Pulse Biosciences common stock on December 15, 2017.

December 15, 2017

·

2 min read

Pharm Country

Pfizer Inc. Announces Expiration and Results of Its Private Exchange Offer for Its 6.500 Per Cent. Notes Due 2038 and Related Tender Offer

Pfizer announced the expiration and results of its previously announced offers to exchange and to repurchase any and all of its outstanding £1,500,000,000 6.500 per cent.

December 15, 2017

·

11 min read